SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-020010
Filing Date
2024-05-02
Accepted
2024-05-02 16:10:06
Documents
16
Period of Report
2024-05-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crdf-20240502.htm   iXBRL 8-K 31126
2 EX-99.1 crdf033124-q12024pr.htm EX-99.1 103447
6 crdf-20240502_g1.jpg GRAPHIC 2732
7 image_0a.jpg GRAPHIC 7491
  Complete submission text file 0001628280-24-020010.txt   283377

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crdf-20240502.xsd EX-101.SCH 1925
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crdf-20240502_lab.xml EX-101.LAB 20770
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crdf-20240502_pre.xml EX-101.PRE 12001
19 EXTRACTED XBRL INSTANCE DOCUMENT crdf-20240502_htm.xml XML 2607
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35558 | Film No.: 24908298
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)